Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Owen

Showing results (71-80 of 262) with videos related to

Pageof 27
Sort By:
Annals of Epidemiology|December 22, 2024
Gender differences in physical activity and sport participation in adults across 28 European countries between 2005 and 2022Katherine B Owen, Lucy Corbett, Ding Ding, et al.
Genome Research|August 7, 2003
A gene recommender algorithm to identify coexpressed genes in C. elegansArt B Owen, Josh Stuart, Kathy Mach, et al.
Clinical & Experimental Metastasis|September 25, 2004
Essential role for hematopoietic Fas ligand (FasL) in the suppression of melanoma lung metastasis revealed in bone marrow chimeric miceChristopher L Hall, Mike Yao, Laurie L Hill, et al.
Statistics in Medicine|October 21, 2021
Propensity score methods for merging observational and experimental datasetsEvan T R Rosenman, Art B Owen, Mike Baiocchi, et al.
Cancer Research|March 15, 1994
Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsivenessL B Owen-Schaub, R Radinsky, E Kruzel, et al.
Cellular Immunology|March 1, 1992
DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagementL B Owen-Schaub, S Yonehara, W L Crump, et al.
Applied Optics|July 9, 2002
Microgravity materials and life sciences research applications of digital holographyRobert B Owen, Alex A Zozulya, Michael R Benoit, et al.
Cellular Immunology|January 1, 1988
Functional differentiation of human lymphokine-activated killing (LAK) is distinct from expansion and involves dissimilar interleukin 2 receptorsL B Owen-Schaub, W G Loudon, M Yagita, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1992
Factors affecting treatment patterns of radiation oncologists in the United States in the palliative treatment of cancerL R Coia, J B Owen, E J Maher, et al.
Cancer|December 15, 1994
Progress in the treatment of Hodgkin's disease in the United States, 1973 versus 1983. The Patterns of Care StudyR T Hoppe, A L Hanlon, G E Hanks, et al.
Pageof 27

Showing results (71-80 of 262) with videos related to

Sort By:
Pageof 27
Annals of Epidemiology|December 22, 2024
Gender differences in physical activity and sport participation in adults across 28 European countries between 2005 and 2022Katherine B Owen, Lucy Corbett, Ding Ding, et al.
Genome Research|August 7, 2003
A gene recommender algorithm to identify coexpressed genes in C. elegansArt B Owen, Josh Stuart, Kathy Mach, et al.
Clinical & Experimental Metastasis|September 25, 2004
Essential role for hematopoietic Fas ligand (FasL) in the suppression of melanoma lung metastasis revealed in bone marrow chimeric miceChristopher L Hall, Mike Yao, Laurie L Hill, et al.
Statistics in Medicine|October 21, 2021
Propensity score methods for merging observational and experimental datasetsEvan T R Rosenman, Art B Owen, Mike Baiocchi, et al.
Cancer Research|March 15, 1994
Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsivenessL B Owen-Schaub, R Radinsky, E Kruzel, et al.
Cellular Immunology|March 1, 1992
DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagementL B Owen-Schaub, S Yonehara, W L Crump, et al.
Applied Optics|July 9, 2002
Microgravity materials and life sciences research applications of digital holographyRobert B Owen, Alex A Zozulya, Michael R Benoit, et al.
Cellular Immunology|January 1, 1988
Functional differentiation of human lymphokine-activated killing (LAK) is distinct from expansion and involves dissimilar interleukin 2 receptorsL B Owen-Schaub, W G Loudon, M Yagita, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1992
Factors affecting treatment patterns of radiation oncologists in the United States in the palliative treatment of cancerL R Coia, J B Owen, E J Maher, et al.
Cancer|December 15, 1994
Progress in the treatment of Hodgkin's disease in the United States, 1973 versus 1983. The Patterns of Care StudyR T Hoppe, A L Hanlon, G E Hanks, et al.
Pageof 27